InMedica (IMS Research) drops another shoeful of data in its latest publication ‘Analysis of Demand Dynamics’ [TA 4 Jan] by predicting a global rise to 1.8 million patients annually by 2017, up from 308,000 patients in 2012 remotely monitored by their providers. The majority of currently monitored patients have congestive heart failure (CHF) followed by chronic obstructive pulmonary disease (COPD), but by 2017 InMedica projects that COPD will be surpassed by diabetes. InMedica release
Related: A large N (8,000) study finally on telemedicine virtual visits published by JAMA Internal Medicine compares the quality of patient care between ‘e-visits’ and in-person visits. Patients had sinus infections and urinary tract infections and were surveyed between January 2010 and May 2011. For both patient groups, 7% or less returned for another consultation within three weeks. This suggests that both forms of visits have the same quality–and the e-visit cost 21% less. JAMA 14 January. Institute for HealthCare Consumerism (also InMedica)
Most Recent Comments